Skip to main content
. 2021 Sep 10;27:e932227-1–e932227-10. doi: 10.12659/MSM.932227

Table 2.

Characteristics of patients with sepsis.

All patients (n=294) Non-septic shock Septic shock
Survival (n=74) Death (n=80) P Survival (n=51) Death (n=89) P
Age, years, median (Q1, Q3) 67 (55–76) 66 (51–74) 70 (56–78) 0.067 62 (53–74) 67 (58–79) 0.087
Male, n (%) 185 (62.9) 43 (58.1) 57 (71.3) 0.088 28 (54.9) 57 (64.0) 0.286
Household registration 0.063 0.849
 Countryside 180 (61.2) 48 (64.9) 40 (50.0) 33 (64.7) 59 (66.3)
 Urban 114 (38.8) 26 (35.1) 40 (50.0) 18 (35.3) 30 (33.7)
Patient sources 0.008 <0.001
 Emergency treatment 69 (23.5) 11 (14.9) 22 (27.5) 5 (9.8) 31 (34.8)
 Postoperative transfer 55 (18.7) 19 (25.7) 6 (7.5) 20 (39.2) 10 (11.2)
 General wards (including general wards and their ICU) 151 (51.4) 36 (48.6) 46 (57.5) 26 (51.0) 43 (48.3)
 Specialty or ICU from other hospitals 19 (6.5) 8 (10.8) 6 (7.5) 0 (0) 5 (5.6)
Major diseases to ICU 0.246 0.032
 Respiratory diseases 113 (38.4) 29 (39.2) 44 (55.0) 10 (19.6) 30 (33.7)
 Circulatory diseases 10 (3.4) 2 (2.7) 2 (2.5) 0 (0) 6 (6.7)
 Diseases of digestive system 92 (31.3) 23 (32.1) 12 (15.0) 26 (51.0) 31 (34.8)
 Neurological diseases 25 (8.5) 4 (5.4) 9 (11.3) 3 (5.9) 9 (10.1)
 Endocrine system diseases 5 (1.7) 1 (1.4) 2 (2.5) 0 (0) 2 (2.2)
 Diseases of urinary system 22 (7.5) 6 (8.1) 4 (5.0) 8 (15.7) 4 (4.5)
 Hematological diseases 4 (1.4) 1 (1.4) 1 (1.3) 0 (0) 2 (2.2)
 Rheumatic immune system diseases 1 (0.3) 0 (0) 1 (1.3)
 Trauma 10 (3.4) 3 (4.1) 3 (3.8) 2 (3.9) 2 (2.2)
 Other 12 (4.1) 5 (6.8) 2 (2.5) 2 (3.9) 3 (3.4)
Underlying diseases
 None 90 (30.6) 27 (36.5) 20 (25.0) 0.122 21 (41.2) 22 (24.7) 0.042
 Coronary heart disease 45 (15.3) 6 (8.1) 17 (21.3) 0.022 5 (9.8) 17 (19.1) 0.146
 Diabetes 60 (20.4) 18 (24.3) 19 (25.6) 0.934 6 (11.8) 17 (19.1) 0.260
 Malignant tumors 22 (7.5) 4 (5.4) 5 (6.3) 1.000 3 (5.9) 10 (11.2) 0.455
 Autoimmune diseases 11 (3.7) 2 (27) 7 (8.8) 0.210 2 (3.9) 0 (0) 0.131
 Chronic renal insufficiency and failure 18 (6.1) 6 (8.1) 7 (8.8) 0.886 1 (2.0) 4 (4.5) 0.761
 Hypertension 95 (32.3) 22 (29.7) 35 (43.8) 0.072 8 (15.7) 30 (33.7) 0.021
 Chronic obstructive pulmonary disease 34 (11.6) 10 (13.5) 11 (13.8) 0.966 2 (3.9) 11 (12.4) 0.176
 Sequelae of cerebrovascular accident 18 (6.1) 3 (4.1) 8 (10.0) 0.152 3 (5.9) 4 (4.5) 1.000
 Other 65 (22.1) 14 (18.9) 16 (20.0) 0.866 11 (21.6) 24 (27.0) 0.478
Chronic organ dysfunction
 Chronic cardiac insufficiency 22 (7.5) 4 (5.4) 7 (8.8) 0.421 1 (2.0) 10 (11.2) 0.102
 Chronic respiratory insufficiency 41 (13.9) 10 (13.5) 16 (20.0) 0.283 5 (9.8) 10 (11.2) 0.792
 Chronic hepatic insufficiency 6 (2.0) 0 (0.0) 3 (3.8) 0.272 0 (0) 3 (3.4) 0.472
 Immunosuppression 17 (5.8) 2 (2.7) 7 (8.8) 0.210 2 (3.9) 6 (6.7) 0.754
 Chronic renal insufficiency 6 (2.0) 3 (4.1) 1 (1.3) 0.558 1 (2.0) 1 (1.1) 1.000
 None 210 (71.4) 56 (75.7) 52 (65.0) 0.148 43 (84.3) 59 (66.3) 0.021
Number of acute organ dysfunction 0.016 0.182
 1 3 (1.0) 1 (1.4) 1 (1.3) - 1 (2.0) 0 (0)
 2 33 (11.3) 19 (25.7) 11 (13.8) 0 (0) 3 (3.4)
 3 63 (21.5) 26 (35.1) 18 (22.5) 9 (17.6) 10 (11.4)
 ≥4 194 (66.2) 28 (37.8) 50 (62.5) 41 (80.4) 75 (85.2)
Acute organ dysfunction involvement system (scored by sequential organ failure score (SOFA))
 Respiratory system 282 (96.2) 67 (90.5) 79 (98.8) 0.054 49 (96.1) 87 (98.9) 0.629
 Coagulation system 186 (63.5) 47 (63.5) 47 (58.8) 0.545 38 (74.5) 54 (61.4) 0.114
 Liver 116 (39.6) 25 (33.8) 31 (38.8) 0.522 18 (35.3) 42 (47.7) 0.154
 Cardiovascular system 200 (68.3) 26 (35.1) 41 (51.3) 0.044 48 (94.1) 85 (96.6) 0.796
 Central nervous system 236 (80.5) 45 (60.8) 69 (86.3) 0.000 40 (78.4) 82 (93.2) 0.011
 Kidney 170 (58.0) 34 (45.9) 39 (48.8) 0.728 31 (60.8) 66 (75.0) 0.079
Infection type 0.719 0.647
 Community infection 247 (84) 60 (81.1) 63 (78.8) 46 (90.2) 78 (87.6)
 Hospital acquired infections 47 (16) 14 (18.9) 17 (21.2) 5 (9.8) 11 (12.4)